Your browser doesn't support javascript.
loading
Indole and azaindole halogenation catalyzed by the RebH enzyme variant 3-LSR utilizing co-purified E. coli reductase.
Li, Eunice Hui Yen; Sana, Barindra; Ho, Timothy; Ke, Ding; Ghadessy, Farid J; Duong, Hung A; Seayad, Jayasree.
Afiliación
  • Li EHY; Institute of Sustainability for Chemicals, Energy and Environment, ASTAR, Singapore, Singapore.
  • Sana B; Disease Intervention Technology Laboratory, Institute of Molecular and Cellular Biology, ASTAR, Singapore, Singapore.
  • Ho T; Institute of Sustainability for Chemicals, Energy and Environment, ASTAR, Singapore, Singapore.
  • Ke D; Disease Intervention Technology Laboratory, Institute of Molecular and Cellular Biology, ASTAR, Singapore, Singapore.
  • Ghadessy FJ; Disease Intervention Technology Laboratory, Institute of Molecular and Cellular Biology, ASTAR, Singapore, Singapore.
  • Duong HA; Institute of Sustainability for Chemicals, Energy and Environment, ASTAR, Singapore, Singapore.
  • Seayad J; Institute of Sustainability for Chemicals, Energy and Environment, ASTAR, Singapore, Singapore.
Front Bioeng Biotechnol ; 10: 1032707, 2022.
Article en En | MEDLINE | ID: mdl-36588932
ABSTRACT
Biocatalytic C-H halogenation is becoming increasingly attractive due to excellent catalyst-controlled selectivity and environmentally benign reaction conditions. Significant efforts have been made on enzymatic halogenation of industrial arenes in a cost-effective manner. Here we report an unprecedented enzymatic halogenation of a panel of industrially important indole, azaindole and anthranilamide derivatives using a thermostable RebH variant without addition of any external flavin reductase enzyme. The reactions were catalyzed by the RebH variant 3-LSR enzyme with the help of a co-purified E. coli reductase identified as alkyl hydroperoxide reductase F (AhpF).
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Bioeng Biotechnol Año: 2022 Tipo del documento: Article